Effect of semaglutide on primary prevention of diabetic kidney disease in people with type 2 diabetes: A post hoc analysis of the SUSTAIN 6 randomized controlled trial.
Jingyu WangJuhong YangWenhui JiangWenyan LiuZewei ShenZhongai GaoBao Cheng ChangPublished in: Diabetes, obesity & metabolism (2024)
This post hoc study indicates that semaglutide may have beneficial effects on primary DKD prevention in people with T2D.